This narrative review focuses on adenomyosis in the context of assisted reproductive technology. The authors observe that adenomyosis is increasingly identified in women of reproductive age and may have a detrimental effect on fertility, ART outcomes and pregnancy.
The paper underscores ongoing uncertainty about how best to manage adenomyosis in women pursuing pregnancy. The evidence base is hindered by considerable variability in diagnostic criteria, a range of disease phenotypes and uneven therapeutic data.
Informed by a multidisciplinary discussion at the Naples Workshop on Adenomyosis and ART (10th–12th October 2025), the review offers a critical appraisal of available evidence across the ART pathway, aiming to clarify current knowledge and gaps.
Why it matters: The review draws attention to uncertainty about optimal management and to heterogeneity in diagnostic criteria, phenotypes and therapeutic evidence that relate to fertility, ART outcomes and pregnancy.
Source: Fertility and Sterility · 15 Nov 2026
This summary was prepared with AI assistance from the source below and is provided for professional information only. Please read the original source before relying on any information. It is not medical advice.